Title: Getting an insight in the determinants of new product introductions of US biopharmaceutical start-ups
Authors: Clarysse, B ×
Debackere, Koenraad #
Issue Date: 2001
Series Title: International Journal of Biotechnology vol:3 issue:1 pages:33-56
Abstract: A study analyses which organizational and industrial factors influence the chance that a US biopharmaceutical start-up is able to introduce a new drug on the US market. Specific attention is paid to the critical mass a biotech company should obtain to improve its chances of bringing a new drug to the market. In the same vein, the economies of scale in R&D are taken into consideration. Second, the study analyses whether a biotech start-up can obtain this optimal scale through merger, internal growth financed by the minority participations of larger partners or through strategic alliances with a pharmaceutical partner. Data on NDA and R&D activities is collected for all US biotech companies, involved in biopharmaceutical R&D, with more than 50 employees over the period 1982-1994
ISSN: 0963-6048
VABB publication type: VABB-1
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Department of Managerial Economics, Strategy and Innovation (MSI), Leuven
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.